FDA SiIGNALS IT WILL REFORM PHARMACY COMPOUNDING DRUGS ADVISORY COMMITTEE

In With The Old? 2013 To Mark Rebirth Of CDER’s Pharmacy Compounding, Medical Imaging AdComms

By Sue Sutter / Email the Author / Jan. 14, 2013
Year In Review And The Year Ahead / Word Count: 3003 / Article # 00130114001 / Posted:January 14 2013 12:01 AM

---

Executive Summary

FDA has signaled that it will re-form its Pharmacy Compounding Drugs Advisory Committee, which was dissolved in 2002, as it deals with an ongoing meningitis outbreak related to compounded steroid injections. 2012 proved to be another busy year for the Oncologic Drugs Advisory Committee, but the full drug safety/risk management panel saw a significantly lighter workload than in recent years.

To purchase article click here

CDER Sponsored Meetings, Conferences and Workshops

Meetings, Conferences, & Workshops (Drugs)

The following are meetings, conferences, and workshops sponsored or co-sponsored by the Center for Drug Evaluation and Research (CDER):

Upcoming 

• FDA Small Business Regulatory Education for Industry (REdI) Conference Spring 2012, June 19-20, 2012
• DIA/FDA: Revitalizing Productivity in Drug Development, October 23, 2012, 5151 Pooks Hill Road, Bethesda, MD. Meeting
• The Regulatory Convergence, October 26–30, 2012, Seattle, WA. 
• CDER Forum for International Drug Regulatory Authorities, November 5-9, 2012, College Park, MD. 
• PDA Pharmaceutical Quality Systems (ICHQ10) Conference, November 15-16, 2012
•  

For more information on these meetings, click here.